TNDM (STOCKS)
Tandem Diabetes Care, Inc.
$22.714100
-0.725900 (-3.10%)
Prev close: $23.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- John F. Sheridan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,875.85M
- Employees
- 2,650
- P/E (TTM)
- -24.97
- P/B (TTM)
- 12.50
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
11
Buy
11
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.31 | $-0.33 | +0.0161 | +4.94% |
|
Mar 2026 (Q1)
|
$-0.30 | $-0.45 | +0.1532 | +33.80% |
|
Dec 2025 (Q4)
|
$-0.01 | $-0.08 | +0.0739 | +88.08% |
|
Sep 2025 (Q3)
|
$-0.31 | $-0.32 | +0.0102 | +3.19% |
Financial Statements
| Revenues | $1.04B |
| Benefits Costs and Expenses | $816.71M |
| Cost Of Revenue | $458.10M |
| Costs And Expenses | $1.10B |
| Gross Profit | $583.32M |
| Operating Expenses | $629.12M |
| Selling, General, and Administrative Expenses | $441.37M |
| Other Operating Expenses | $172.65M |
| Operating Income/Loss | -$45.80M |
| Income/Loss Before Equity Method Investments | -$44.21M |
| Income/Loss From Continuing Operations After Tax | -$63.32M |
| Income/Loss From Continuing Operations Before Tax | $224.71M |
| Income/Loss From Equity Method Investments | -$16.78M |
| Income Tax Expense/Benefit | $2.32M |
| Net Income/Loss | -$63.32M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$63.32M |
| Net Income/Loss Available To Common Stockholders, Basic | -$63.32M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.92 |
| Diluted Earnings Per Share | -$0.92 |
| Basic Average Shares | 204,372,000 |
| Diluted Average Shares | 204,372,000 |
| Assets | $1.15B |
| Current Assets | $804.64M |
| Inventory | $135.11M |
| Other Current Assets | $669.53M |
| Noncurrent Assets | $349.56M |
| Fixed Assets | $84.50M |
| Other Non-current Assets | $265.06M |
| Liabilities | $1.02B |
| Current Liabilities | $253.01M |
| Accounts Payable | $64.13M |
| Wages | $53.26M |
| Other Current Liabilities | $135.61M |
| Noncurrent Liabilities | $770.81M |
| Commitments and Contingencies | $0.00 |
| Equity | $130.39M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $130.39M |
| Liabilities And Equity | $1.15B |
| Net Cash Flow From Operating Activities | -$5.52M |
| Net Cash Flow From Operating Activities, Continuing | -$5.52M |
| Net Cash Flow From Investing Activities | -$277.22M |
| Net Cash Flow From Investing Activities, Continuing | -$277.22M |
| Net Cash Flow From Financing Activities | $277.35M |
| Net Cash Flow From Financing Activities, Continuing | $277.35M |
| Exchange Gains/Losses | $4.10M |
| Net Cash Flow | -$1.29M |
| Net Cash Flow, Continuing | -$5.40M |
| Comprehensive Income/Loss | -$61.08M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$61.08M |
| Other Comprehensive Income/Loss | -$18.93M |